Genesis Molecular AI claims its model Pearl beats AlphaFold 3news2025-10-28T18:30:15+00:00October 28th, 2025|Endpoints News|
Takeaways from Endpoints AI Day: Real progress, ‘stupid’ money and moonshotsnews2025-10-27T14:00:29+00:00October 27th, 2025|Endpoints News|
Tahoe Therapeutics releases virtual cell AI modelnews2025-10-23T11:00:43+00:00October 23rd, 2025|Endpoints News|
Amy Gleason, a top Trump health official, calls for more access to patient datanews2025-10-22T18:59:33+00:00October 22nd, 2025|Endpoints News|
Flagship debuts AI biotech startup Expedition with $50Mnews2025-10-22T10:30:19+00:00October 22nd, 2025|Endpoints News|
Chemify raises $50M+ Series B to scale molecule-making businessnews2025-10-21T12:00:17+00:00October 21st, 2025|Endpoints News|
Interview with Anthropic’s life sciences head on AI in bio productnews2025-10-20T10:00:16+00:00October 20th, 2025|Endpoints News|
Lila Sciences closes $350M Series A, bringing in Nvidianews2025-10-14T13:41:42+00:00October 14th, 2025|Endpoints News|
Bristol Myers, insitro extend ALS drug research dealnews2025-10-14T11:00:40+00:00October 14th, 2025|Endpoints News|
Takeda, Nabla Bio sign second research deal for AI-made proteinsnews2025-10-14T09:00:52+00:00October 14th, 2025|Endpoints News|
